MYRIAD GENETICS INC

SALT LAKE CITY, UT How do I update this listing?

Myriad Genetics is based out of Salt Lake City. Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).Whalewisdom has at least 376 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2019-02-12. The notice included securities offered of Equity

Create Email Alert

Contact Info

myriad genetics inc
320 WAKARA WAY
SALT LAKE CITY UT    84108

Business Phone: 801-584-3600
SEC SIC CODE:
2835-IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2019-02-12 D/A BIOTECHNOLOGY Equity 249,390 249,390 0
2017-11-14 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security INDEFINITE 0 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALEXANDER FORD subscription required
    EXECUTIVE OFFICER
BERNARD F. TOBIN subscription required
    EXECUTIVE OFFICER
DENNIS LANGER subscription required
    DIRECTOR
GARY A. KING subscription required
    EXECUTIVE OFFICER
HELNER DREISMANN subscription required
    DIRECTOR
JERRY S. LANCHBURY subscription required
    EXECUTIVE OFFICER
JOHN T. HENDERSON subscription required
    DIRECTOR
LAWRENCE C. BEST subscription required
    DIRECTOR
MARK C. CAPONE subscription required
    EXECUTIVE OFFICER DIRECTOR
MARK VERRATTI subscription required
    EXECUTIVE OFFICER
RALPH L. MCDADE subscription required
    EXECUTIVE OFFICER
RICHARD MARSH subscription required
    EXECUTIVE OFFICER
RICHARD BRYAN RIGGSBEE subscription required
    EXECUTIVE OFFICER
S. LOUISE PHANSTIEL subscription required
    DIRECTOR
W. LLOYD SANDERS subscription required
    EXECUTIVE OFFICER
WALTER GILBERT subscription required
    DIRECTOR

Elevate your investments